DAVID TOPPER

David Topper stands as a distinguished Partner at Frazier Healthcare Partners, a prominent private equity firm exclusively dedicated to the healthcare industry. In his pivotal role, Mr. Topper is responsible for sourcing, evaluating, and executing growth equity investments, contributing significantly to Frazier's mission of partnering with innovative healthcare companies to accelerate their growth and market leadership.

His investment focus at Frazier Healthcare Partners spans a broad spectrum of the healthcare landscape, including healthcare services, healthcare information technology, medical devices, and pharmaceutical services. David is particularly adept at identifying companies with strong management teams, proven business models, and significant growth potential, providing them with strategic capital and operational expertise to scale effectively. His approach emphasizes collaborative partnerships, working closely with portfolio company leadership to navigate market complexities and achieve strategic objectives.

Before joining Frazier Healthcare Partners in 2013, David Topper honed his expertise in growth equity investing at Summit Partners, a global alternative investment firm. During his tenure there, he gained valuable experience across various sectors, further solidifying his foundation in identifying high-growth opportunities. Prior to his career in private equity, Mr. Topper began his professional journey in investment banking at Morgan Stanley, where he developed a robust understanding of financial markets and corporate transactions. This diverse background provides him with a comprehensive perspective on investment strategies and value creation.

Throughout his career at Frazier, David Topper has been actively involved with numerous successful investments, often serving on the boards of directors for portfolio companies. While specific investment details are proprietary, his work has consistently focused on companies poised for significant expansion within their respective healthcare niches. His contributions have helped these companies enhance their market position, expand their services, and ultimately improve patient outcomes and healthcare efficiency. David's commitment to fostering innovation and growth within the healthcare ecosystem underscores his impact as a leader in the private equity space.